Sandra Senno, MD | |
31 Maple Ave, Hampstead, NH 03841-5314 | |
(603) 329-7122 | |
Not Available |
Full Name | Sandra Senno |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 31 Maple Ave, Hampstead, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326195355 | NPI | - | NPPES |
043704421 | Other | MA | TAX ID |
0189341 | Medicaid | MA | |
J25704 | Other | MA | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 156209 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sandra Senno, MD Po Box 1032, Atkinson, NH 03811-1032 Ph: (603) 329-7122 | Sandra Senno, MD 31 Maple Ave, Hampstead, NH 03841-5314 Ph: (603) 329-7122 |
News Archive
Although radiation treatments have become much more refined in recent years, it remains a challenge to both sufficiently dose the tumor while sparing the surrounding tissue.
Government and private sector cancer scientists today launched a research partnership to find biomarkers for lung cancer that develops in people who have never smoked. The research studies are designed to create a better understanding of the biology of lung cancer and to develop a test to detect early-stage lung cancer in lifetime nonsmokers.
Today, Novo Nordisk launches NovoRapid PumpCart, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps. This new treatment solution, which contains NovoRapid (insulin aspart) – a rapid-acting insulin from Novo Nordisk – is expected to make insulin pump therapy more convenient for people with diabetes and their care staff.
A study published in the July issue of The American Journal of Medicine, reports that among hypertensive patients with coronary artery disease, chronic self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of adverse events during long-term follow-up. Long-term NSAID use is common for treatment of chronic pain.
› Verified 6 days ago